JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seals, J. R.
Right arrow Articles by Czech, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seals, J. R.
Right arrow Articles by Czech, M. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 255, Issue 14, 6529-6531, 07, 1980

Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator

JR Seals and MP Czech

Three lines of evidence are presented which support the hypothesis that the binding of insulin to rat adipocyte plasma membranes activates a membrane protease which results in the production of a soluble factor that stimulates pyruvate dehydrogenase activity when added to mitochondria. First, low concentrations of trypsin (0.01 to 0.1 microgram/ml) mimic the action of insulin on plasma membranes in this system. Second, inhibitors of trypsin-like proteases (soy trypsin inhibitor, ovomucoid) block insulin action on the plasma membrane, as do exogenous protease substrates which are esters of arginine, presumably by preventing the normal interaction of the protease and its endogenous membrane substrate. Third, digestion by proteases (0.1 mg/ml of trypsin, chymotrypsin, or papain) of the soluble material released from plasma membranes after insulin treatment blocks the stimulation of pyruvate dehydrogenase, suggesting that the mediator may be a peptide released by a proteolytic reaction.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ScienceHome page
G Romero, L Luttrell, A Rogol, K Zeller, E Hewlett, and J Larner
Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators
Science, April 22, 1988; 240(4851): 509 - 511.
[Abstract] [PDF]


Home page
ScienceHome page
A. Saltiel, J. Fox, P Sherline, and P Cuatrecasas
Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase
Science, August 29, 1986; 233(4767): 967 - 972.
[Abstract] [PDF]


Home page
ScienceHome page
L Jarett, E. Wong, S. Macaulay, and J. Smith
Insulin mediators from rat skeletal muscle have differential effects on insulin-sensitive pathways of intact adipocytes
Science, February 1, 1985; 227(4686): 533 - 535.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1980 by the American Society for Biochemistry and Molecular Biology.